Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hogg

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Microbiome|January 11, 2024
Biogeographic survey of soil bacterial communities across AntarcticaGilda Varliero, Pedro H Lebre, Byron Adams, et al.
Science Translational Medicine|July 5, 2019
Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapiesRoheena Z Panni, John M Herndon, Chong Zuo, et al.
Scientific Reports|January 18, 2025
Novel adaptive immune systems in pristine Antarctic soilsMarc W Van Goethem, Oliver K I Bezuidt, Rian Pierneef, et al.
Cancer Immunology Research|May 25, 2023
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic CancerC Alston James, John M Baer, Chong Zou, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Cancer Cell|March 19, 2020
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic CancerSamarth Hegde, Varintra E Krisnawan, Brett H Herzog, et al.
Cancer Discovery|September 27, 2022
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint BlockadeVarintra E Lander, Jad I Belle, Natalie L Kingston, et al.
Cancer Cell|May 26, 2023
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunityXiuting Liu, Graham D Hogg, Chong Zuo, et al.
Science Translational Medicine|October 23, 2024
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapyXiuting Liu, John M Baer, Meredith L Stone, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Microbiome|January 11, 2024
Biogeographic survey of soil bacterial communities across AntarcticaGilda Varliero, Pedro H Lebre, Byron Adams, et al.
Science Translational Medicine|July 5, 2019
Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapiesRoheena Z Panni, John M Herndon, Chong Zuo, et al.
Scientific Reports|January 18, 2025
Novel adaptive immune systems in pristine Antarctic soilsMarc W Van Goethem, Oliver K I Bezuidt, Rian Pierneef, et al.
Cancer Immunology Research|May 25, 2023
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic CancerC Alston James, John M Baer, Chong Zou, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Cancer Cell|March 19, 2020
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic CancerSamarth Hegde, Varintra E Krisnawan, Brett H Herzog, et al.
Cancer Discovery|September 27, 2022
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint BlockadeVarintra E Lander, Jad I Belle, Natalie L Kingston, et al.
Cancer Cell|May 26, 2023
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunityXiuting Liu, Graham D Hogg, Chong Zuo, et al.
Science Translational Medicine|October 23, 2024
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapyXiuting Liu, John M Baer, Meredith L Stone, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Pageof 13